Medication info
Unirabeph Tablet 20 mg (Rabeprazole Sodium)

Unirabeph Tablet 20 mg (Rabeprazole Sodium)

Prescription medicationTabletOral
Ingredient · strength
Rabeprazole Sodium›20mg / 1 tablet
Manufacturer / importer
Korea Union Pharmaceutical Co., Ltd.
Appearance
Light yellow round enteric-coated tablet
Packaging
28 tablets/box [14 tablets/Alu Alu packaging x 2]
Approval status
Active

MFDS item code 201901302 · Approved 2019.03.04 · Insurance code 665507090

Summary

Main use
Treatment of gastroesophageal reflux disease, ulcers, Helicobacter pylori eradication, and Zollinger-Ellison syndrome
Who takes it
Adults · Children
Adult dose
Gastric ulcer, duodenal ulcer The usual adult dosage is 10 mg of rabeprazole sodium orally once daily. Depending on symptoms, 20 mg may be administered orally once daily. Treatment is usually continued for up to 8 weeks for gastric ulcers and up to 6 weeks for duodenal ulcers. Erosive or ulcerative gastroesophageal reflux disease Administer 10 mg or 20 mg once daily for 4 ∼ 8 weeks. If the condition has not healed after 8 weeks of treatment with a proton pump inhibitor (PPI), an additional 8 weeks of oral treatment with 10 mg or 20 mg twice daily may be given. However, the 20 mg twice-daily dosage is limited to patients with confirmed severe mucosal damage. Relief of symptoms of gastroesophageal reflux disease Administer 10 mg once daily. If symptoms are not controlled after 4 weeks of treatment, further evaluation is required. After symptoms resolve, subsequent symptoms may be controlled using on-demand therapy with 10 mg once daily as needed. Long-term maintenance therapy for gastroesophageal reflux disease Administer 10 mg or 20 mg orally once daily, depending on the patient. Helicobacter pylori eradication Patients infected with Helicobacter pylori should receive eradication therapy. Concomitant administration of this drug 20 mg, clarithromycin 500 mg, and amoxicillin 1 g twice daily for 7 days is recommended. Zollinger-Ellison syndrome The recommended initial dosage for adults is 60 mg once daily. The dosage may be adjusted up to 120 mg daily according to the individual patient's needs. Doses up to 100 mg may be administered once daily, while the 120 mg dose should be divided into 60 mg twice daily. Patients with Zollinger-Ellison syndrome have been treated with this drug for up to 1 year. Patients with hepatic impairment Adverse reactions of hepatic encephalopathy have been reported in patients with cirrhosis. Therefore, administer with caution. Older adults Administer with caution, as hepatic function is often reduced.
Child dose
Safety in children has not been established.

Ingredients

Manufacturer
Korea Union Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of gastroesophageal reflux disease, ulcers, Helicobacter pylori eradication, and Zollinger-Ellison syndrome

  • Gastric ulcer
  • duodenal ulcer
  • erosive gastroesophageal reflux disease
  • ulcerative gastroesophageal reflux disease
  • symptoms of gastroesophageal reflux disease
  • gastrointestinal ulcer
  • Zollinger-Ellison syndrome
View approved original text

This medication is used for the treatment of gastrointestinal ulcers such as gastric and duodenal ulcers. It also helps in the treatment and symptom relief of erosive or ulcerative gastroesophageal reflux disease. It is effective for long-term maintenance therapy of gastroesophageal reflux disease and is used in combination with antibiotics for patients infected with Helicobacter pylori. It is also used for conditions of excessive gastric acid secretion such as Zollinger-Ellison syndrome. Overall, it helps improve gastrointestinal and esophageal-related conditions.

How to take

Adult dose

Gastric ulcer, duodenal ulcer The usual adult dosage is 10 mg of rabeprazole sodium orally once daily. Depending on symptoms, 20 mg may be administered orally once daily. Treatment is usually continued for up to 8 weeks for gastric ulcers and up to 6 weeks for duodenal ulcers. Erosive or ulcerative gastroesophageal reflux disease Administer 10 mg or 20 mg once daily for 4 ∼ 8 weeks. If the condition has not healed after 8 weeks of treatment with a proton pump inhibitor (PPI), an additional 8 weeks of oral treatment with 10 mg or 20 mg twice daily may be given. However, the 20 mg twice-daily dosage is limited to patients with confirmed severe mucosal damage. Relief of symptoms of gastroesophageal reflux disease Administer 10 mg once daily. If symptoms are not controlled after 4 weeks of treatment, further evaluation is required. After symptoms resolve, subsequent symptoms may be controlled using on-demand therapy with 10 mg once daily as needed. Long-term maintenance therapy for gastroesophageal reflux disease Administer 10 mg or 20 mg orally once daily, depending on the patient. Helicobacter pylori eradication Patients infected with Helicobacter pylori should receive eradication therapy. Concomitant administration of this drug 20 mg, clarithromycin 500 mg, and amoxicillin 1 g twice daily for 7 days is recommended. Zollinger-Ellison syndrome The recommended initial dosage for adults is 60 mg once daily. The dosage may be adjusted up to 120 mg daily according to the individual patient's needs. Doses up to 100 mg may be administered once daily, while the 120 mg dose should be divided into 60 mg twice daily. Patients with Zollinger-Ellison syndrome have been treated with this drug for up to 1 year. Patients with hepatic impairment Adverse reactions of hepatic encephalopathy have been reported in patients with cirrhosis. Therefore, administer with caution. Older adults Administer with caution, as hepatic function is often reduced.

Child dose

Safety in children has not been established.

Precautions

This medication should not be used in patients with allergies to specific ingredients or a history of hypersensitivity to benzimidazoles. Furthermore, when used in combination with amoxicillin or clarithromycin for the eradication of Helicobacter pylori, it should be avoided in patients with hypersensitivity to penicillin or macrolide antibiotics. It should also be avoided in patients taking specific drugs such as terfenadine, cisapride, pimodipine, astemizole, atazanavir, and rilpivirine. Pregnant or breastfeeding women should not take this medication. Patients with impaired liver function, the elderly, and those with a history of drug hypersensitivity should use this medication cautiously. This medication may cause hypersensitivity reactions such as skin rash, urticaria, and itching; if these symptoms occur, use should be stopped immediately. Regular blood tests are required as there may be changes in red or white blood cell counts. Periodic liver function tests should be conducted as signs of liver dysfunction may appear, and treatment should be stopped if abnormalities are found. Cardiovascular adverse reactions have been reported, so caution is required in cases of hypertension, myocardial infarction, or arrhythmias. Various symptoms such as diarrhea, abdominal pain, nausea, and vomiting may occur, so consult a doctor if such symptoms arise. Neurological symptoms may include headache, insomnia, anxiety, and dizziness; thus, caution is advised. Respiratory symptoms such as cough or dyspnea may also occur, and rarely, interstitial pneumonia may develop, requiring immediate medical attention if fever and dyspnea appear. Musculoskeletal and skin-related side effects may also occur; therefore, consult a healthcare professional if any unusual symptoms arise. This medication suppresses gastric acid secretion and may increase the risk of gastrointestinal bacterial infections, so caution is needed for long-term use. There may be effects such as drowsiness when driving or operating machinery. Interactions with other medications may occur, especially with warfarin, methotrexate, and antibiotics; consult a doctor when using these in combination. This medication should not be used during pregnancy and breastfeeding, and caution should be exercised in the elderly due to the potential for increased side effects from decreased liver function. Safety in children has not been established, so it is advisable not to use it in this population. There are no specific antidotes for overdose, but treatment and supportive therapy according to symptoms are needed. Tablets should not be chewed or crushed and should be swallowed whole, and should be kept out of reach of children. This medication may mask symptoms of malignant tumors, so if malignancies such as gastric cancer are suspected, it must be confirmed before use. During prolonged treatment, especially for more than one year, regular monitoring for adverse effects is necessary. There may be malabsorption of vitamin B12 when taking this medication, so caution is required for long-term use. Autoimmune diseases such as skin and systemic lupus erythematosus may develop or worsen, so consult a healthcare professional immediately if related symptoms occur. If kidney function impairment is suspected, treatment should be stopped, and appropriate measures should be taken.

Side effects

Rash, urticaria, itching, decrease in red blood cells, decrease in white blood cells, increase in white blood cells, increase in eosinophils, increase in neutrophils, decrease in lymphocytes, anemia, petechiae, lymphadenopathy, hypochromic anemia, pancytopenia, agranulocytosis, decrease in platelets, hemolytic anemia, ALT elevation, AST elevation, ALP elevation, γ-GTP elevation, LDH elevation, total bilirubin elevation, fulminant hepatitis, liver dysfunction, jaundice, hypertension, myocardial infarction, electrocardiogram abnormalities, migraine, syncope, angina pectoris, block of conduction pathway, palpitations, bradycardia, tachycardia, pulmonary embolism, ventricular tachycardia, thrombophlebitis, vasodilation, QTc prolongation, ventricular tachycardia, diarrhea, constipation, abdominal pain, abdominal bloating, dyspepsia, belching, nausea, rectal bleeding, bloody stool, anorexia, cholelithiasis, oral ulcers, dysphagia, gingivitis, cholecystitis, increased appetite, abnormal stool, colitis, esophagitis, glossitis, pancreatitis, proctitis, thirst, vomiting, lower abdominal pain, gastric body, gastritis, stomatitis, taste disturbances, hemorrhagic diarrhea, cholangitis, duodenitis, gastrointestinal bleeding, hepatic encephalopathy, hepatitis, liver cancer, hepatic steatosis, salivary gland enlargement, thirst, headache, insomnia, anxiety, dizziness, convulsions, abnormal dreams, decreased libido, neuropathy, sensory disturbances, tremors, weakness, neuroirritability, drowsiness, vertigo, depression, restlessness, amnesia, confusion, extrapyramidal syndrome, excess blood volume, upper and lower limb weakness, sensory ataxia, decreased grip strength, language confusion, staggering, delirium, disorientation, drowsiness, cough, pharyngitis, rhinitis, dyspnea, asthma, epistaxis, laryngitis, hiccups, hyperventilation, bronchitis, sinusitis, apnea, respiratory depression, interstitial pneumonia, myalgia, low back pain, arthritis, leg cramps, bone pain, arthrosis, bursitis, hypermuscletonia, neuralgia, isolated contraction, sweating, alopecia, dry skin, herpes zoster, psoriasis, skin color changes, toxic epidermal necrolysis, mucocutaneous syndrome, erythema multiforme, cataract, amblyopia, glaucoma, dry eye, abnormal vision, tinnitus, otitis media, corneal opacity, blurred vision, double vision, hearing loss, eye pain, retinal degeneration, strabismus, proteinuria, cystitis, increased urination, dysmenorrhea, dysuria, kidney stones, uterine bleeding, polyuria, breast hypertrophy, hematuria, erectile dysfunction, vaginal discharge, menorrhagia, orchitis, urinary incontinence, interstitial nephritis, edema, increased total cholesterol, increased triglycerides, elevated BUN, elevated serum thyroid-stimulating hormone, chest pain, chills, fever, urinary tract infection, erythema, fatigue, weight gain, visual disturbances, anorexia, neck stiffness, phototoxic reaction, hangover effect, weight loss, gout, hepatitis, jaundice, hepatic encephalopathy, sudden death, coma, hyperammonemia, rhabdomyolysis, delirium, anaphylaxis, angioedema, hypomagnesemia, decrease in platelets, decrease in neutrophils, agranulocytosis, hemolytic anemia, pancytopenia, vesicular skin rash, urticarial skin rash, systemic allergic reaction, myalgia, arthralgia, Hashimoto's thyroiditis, elevated thyroid-stimulating hormone, erythema multiforme, toxic epidermal necrolysis, mucocutaneous syndrome, INR increase, prothrombin time increase, bone fracture, Clostridium difficile diarrhea, systemic lupus erythematosus, cutaneous lupus erythematosus, halitosis, dry mouth, chest tightness, allergic reaction, hypertriglyceridemia, hypercholesterolemia, palpitations, increased intraocular pressure, urinary tract infection

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air or moisture, so it must be stored in a tightly closed container. Additionally, it is important to store it at room temperature between 1 degree and 30 degrees Celsius to maintain its effectiveness.

Appearance and packaging

Appearance

Light yellow round enteric-coated tablet

Package unit

28 tablets/box [14 tablets/Alu Alu packaging x 2]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.